These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Selective cyclo-oxygenase-2 inhibitors and myocardial infarction: how strong is the link? Howes LG; Krum H Drug Saf; 2002; 25(12):829-35. PubMed ID: 12241124 [TBL] [Abstract][Full Text] [Related]
53. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective]. MMW Fortschr Med; 2003 May; 145(18):54. PubMed ID: 12808824 [No Abstract] [Full Text] [Related]
54. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective. Hochberg MC Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246 [TBL] [Abstract][Full Text] [Related]
55. [A new class of nonsteroidal anti-inflammatory agents: COXIBs]. Costantino S Clin Ter; 2003; 154(1):5-6. PubMed ID: 12854276 [No Abstract] [Full Text] [Related]
56. COX-2 inhibitors and Celebrex: safe or suspect? Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776 [No Abstract] [Full Text] [Related]
57. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors]. Wigand R Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455 [No Abstract] [Full Text] [Related]
58. Pain management in patients with osteoarthritis. Finucane TE JAMA; 2003 Jul; 290(1):36; author reply 36. PubMed ID: 12837705 [No Abstract] [Full Text] [Related]
59. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)]. Zeidler H MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521 [No Abstract] [Full Text] [Related]